Skip to main content
SUTRO BIOPHARMA, INC. logo

SUTRO BIOPHARMA, INC. — Investor Relations & Filings

Ticker · STRO ISIN · US8693671021 LEI · 5493005U6P15VD25P851 US Manufacturing
Open in API
Filings indexed 585 across all filing types
Latest filing 2023-08-10 Interim / Quarterly Rep…
Country US United States of America
Listing US STRO

About SUTRO BIOPHARMA, INC.

https://www.sutrobio.com/

Sutro Biopharma, Inc. is a clinical-stage biotechnology company focused on the discovery, development, and manufacturing of precisely designed cancer therapeutics. The company leverages its proprietary, integrated cell-free protein synthesis platform to create novel antibody-drug conjugates (ADCs). This technology enables the development of next-generation ADCs, including those with single and dual payloads, which are designed to offer improved therapeutic profiles for patients with cancer. Sutro is advancing its own pipeline of clinical-stage product candidates to address areas of significant unmet medical need.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q2 2023
2023-08-10 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 10, 2023, by Sutro Biopharma, Inc. It announces the issuance of a press release regarding financial results for the quarter ended June 30, 2023. The document itself does not contain the financial results but references an attached press release (Exhibit 99.1). The length of the document is 3662 characters, which is relatively short and primarily serves as an announcement of the earnings release rather than the earnings release itself. According to the 'Menu vs Meal' rule, such a document should be classified as an Earnings Release (ER) if it contains the initial announcement of quarterly financial results. Since the document includes the press release announcing quarterly financial results, it fits the Earnings Release category rather than a full interim report or regulatory filing. Therefore, the appropriate classification is ER with high confidence.
2023-08-10 English
FORM 4 SUBMISSION
Director's Dealing
2023-07-14 English
FORM 4 SUBMISSION
Director's Dealing
2023-06-30 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement involving the sale of a royalty interest and related financial terms. It is not a full financial report, earnings release, or management discussion, but rather an announcement of a significant transaction. The document length is 4469 characters, which is relatively short and consistent with an 8-K current report. Therefore, this filing fits best under the category of Capital/Financing Update (CAP), as it relates to a financing transaction and capital structure change involving a significant payment and contingent payments.
2023-06-26 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes the termination of a material definitive agreement and the submission of matters to a vote of security holders at the 2023 Annual Meeting of Stockholders, including election of directors, ratification of auditors, and approval of executive compensation. The detailed voting results are provided. This matches the description of Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official results from shareholder votes at any general meeting. The document is not an Annual Report, Audit Report, or Management Report, nor is it a simple announcement of a report publication. It contains substantive voting data and is not merely a notice or certification. Therefore, the correct classification is DVA with high confidence.
2023-06-14 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.